OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • February 24th, 2023 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
This Omnibus Amendment to Securities Purchase Agreements, dated as of February 17, 2023 (this “Amendment”), is entered into by and among GRI Bio, Inc., a Delaware corporation (the “PrivateCo”), Vallon Pharmaceuticals, Inc., a Delaware corporation (“PubCo”), and Altium Growth Funds, LP, a New York limited partnership (the “Buyer”) (each a “Party” and collectively, the “Parties”).
AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • February 24th, 2023 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Agreement and Plan of Merger, dated as of February 17, 2023 (this “Amendment”), is entered into by and among Vallon Pharmaceuticals, Inc., a Delaware corporation, Vallon Merger Sub, Inc., a Delaware corporation, and GRI Bio, Inc., a Delaware corporation (each a “Party” and collectively, the “Parties”).
